Zidebactam

Synonym(s): WCK 5107

Class: Beta-lactamase inhibitor

Spectrum of activity:	Gram-negative
Details of activity:	Infections caused by MDR Gram- negative pathogens including enterics and Pseudomonas harbouring metallo-β-lactamases (MBL) as well as carbapenem-hydrolysing (CHDL) Class D β-lactamases in Acinetobacter spp and Klebsiella.
Institute where first reported:	Wockhardt
Year first mentioned:	2017
Highest developmental phase:	Phase 1
Development status:	Active

Chemical structure(s):
Canonical SMILES:	C1C[C@H](CNC1)C(=O)NNC(=O)[C@@H]2CC[C@@H]3CN2C(=O)N3OS(=O)(=O)O
Isomeric SMILES:	C1C[C@H](CNC1)C(=O)NNC(=O)[C@@H]2CC[C@@H]3CN2C(=O)N3OS(=O)(=O)O
InChI:	InChI=1S/C13H21N5O7S/c19-11(8-2-1-5-14-6-8)15-16-12(20)10-4-3-9-7-17(10)13(21)18(9)25-26(22,23)24/h8-10,14H,1-7H2,(H,15,19)(H,16,20)(H,22,23,24)/t8-,9-,10+/m1/s1
InChI Key:	YCZPXRQPDCXTIO-BBBLOLIVSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/77846445

External links:
Guide to Pharmacology:	zidebactam
Main Source:	https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Safety+and+pharmacokinetics+of+multiple+ascending+doses+of+WCK+5107+%28zidebactam%29+and+WCK+5222+%28cefepime+and+zidebactam%29&id=2173&L=0&x=0&y=0
Citation:	https://aac.asm.org/content/61/6/e02529-16